small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
  1. Professionals

Craig L. Godshall

Partner

New York

+1 212-294-6847

Let's Connect

Email
vCard
LinkedIn
  • Full Bio PDFPDF
    • Email
    • LinkedIn
    • Facebook
    • Twitter
    Share this page
  • Overview
  • Experience
  • Credentials
  • Insights & News

Craig focuses his practice on public and private transactions across a wide range of industries, including health care, industrial, and utilities.

Craig structures complex domestic and international transactions on behalf of leading private equity fund sponsors, with a focus on accomplishing successful exits. In many cases, he represents the portfolio companies of his fund sponsor clients in their add-on acquisitions, divestitures, and financings. In addition, he has advised special purpose acquisition companies (SPACs) and potential sellers to SPACs on the dynamics and issues in selling to a SPAC.

Craig has also advised boards, audit committees, and independent committees on sensitive internal investigations involving large multibillion-dollar market capital public companies as well as privately held companies.

From 2007 to 2021, he was a registered foreign lawyer in Hong Kong and provides strategic guidance to both clients in Asia with U.S. transactions and U.S.-based clients engaged in corporate transactions in mainland China.

Key Matters

Some of the experience represented below may have been handled at a previous firm.

Private Equity

  • Represented a company that develops, manufactures, and distributes patient warming solutions designed to prevent hypothermia in surgical settings in its US$810M all-cash sale to an American multinational conglomerate corporation.
  • Represented leading global business process outsourcing company that provides specialized technology-based services to the automotive industry in its sale to a private equity firm.
  • Represented a private equity firm in its acquisition of a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research from a healthcare industry investment bank.
  • Represented a private equity firm in its acquisition of provider of technology-enabled workforce compliance solutions.
  • Represented a private equity firm in its acquisition of a medical supply distributor company.
  • Represented a private equity firm in its acquisition of a digital data collection provider.
  • Represented a private equity company in its US$410M acquisition and subsequent US$813M sale of a global provider of design-to-print graphic services to the consumer products packaging market to  a private equity firm specializing in acquisitions and platform acquisition.
  • Represented a provider of services to direct mail marketers in a series of recapitalizations.
  • Represented a private equity firm in the sale of its portfolio company, which is a provider of upscale and casual serviceware solutions for the foodservice industry, to a private equity company.
  • Represented a marketer of generic pharmaceuticals in its US$1.12B sale to a health care company.

Corporate/M&A

  • Represented a chemicals company in its €111M sale of a research company to a chemical industry company.
  • Represented a dental group specializing in children’s dental care in the acquisition of eight of its offices across California by one of the nation’s largest dental providers.
  • Represented a leading provider of data-driven direct marketing solutions in connection with its sale to a global provider of digital and physical supply chain solutions.
  • Represented a pharmaceutical wholesale distributor in its US$1.3B sale to a health care company.
  • Represented the Special Committee of the Board of Directors of a provider of bulk liquid storage services in its US$419M and US$112M sales of subsidiaries to an agricultural commodity merchant.

Capital Markets

  • Represented an automotive business in its US$220M refinancing of senior secured notes.
  • Represented a physical therapy provider in its US$210M Rule 144A offering of senior unsecured notes.
  • Represented a global graphic design company in its US$200M Rule 144A offering of senior subordinated notes.
  • Represented a SPAC in its US$268M acquisition of a bulk liquid storage and liquid animal supplement businesses of an agricultural commodities distributor.
  • Represented the independent directors of a publicly traded REIT in the internalization of management functions.
Recent Experience
Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B
Court Square Capital Partners's Strategic Capital Investment in Team Select Home Care

Since 2007, Craig has been designated a top lawyer in corporate/M&A and private equity transactions by Chambers USA, which, in recent editions, has cited him for his “top-level technical skills” as well as his “all-around knowledge of corporate transactions” and the “quality of his intellect and argument.” Clients have described him as “a calm and steady negotiator” and “very thorough and easy to work with.” He has also been listed in The Best Lawyers in America® and in The Legal 500 (US), where he is described as “‘particularly excellent’ with ‘a great sense of the overall deal, and a command of detail.’”

  • Member, Law360 Private Equity Editorial Advisory Board

Capabilities

Transactions
Private Equity
Mergers & Acquisitions
Capital Markets

Key Matters

Some of the experience represented below may have been handled at a previous firm.

Private Equity

  • Represented a company that develops, manufactures, and distributes patient warming solutions designed to prevent hypothermia in surgical settings in its US$810M all-cash sale to an American multinational conglomerate corporation.
  • Represented leading global business process outsourcing company that provides specialized technology-based services to the automotive industry in its sale to a private equity firm.
  • Represented a private equity firm in its acquisition of a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research from a healthcare industry investment bank.
  • Represented a private equity firm in its acquisition of provider of technology-enabled workforce compliance solutions.
  • Represented a private equity firm in its acquisition of a medical supply distributor company.
  • Represented a private equity firm in its acquisition of a digital data collection provider.
  • Represented a private equity company in its US$410M acquisition and subsequent US$813M sale of a global provider of design-to-print graphic services to the consumer products packaging market to  a private equity firm specializing in acquisitions and platform acquisition.
  • Represented a provider of services to direct mail marketers in a series of recapitalizations.
  • Represented a private equity firm in the sale of its portfolio company, which is a provider of upscale and casual serviceware solutions for the foodservice industry, to a private equity company.
  • Represented a marketer of generic pharmaceuticals in its US$1.12B sale to a health care company.

Corporate/M&A

  • Represented a chemicals company in its €111M sale of a research company to a chemical industry company.
  • Represented a dental group specializing in children’s dental care in the acquisition of eight of its offices across California by one of the nation’s largest dental providers.
  • Represented a leading provider of data-driven direct marketing solutions in connection with its sale to a global provider of digital and physical supply chain solutions.
  • Represented a pharmaceutical wholesale distributor in its US$1.3B sale to a health care company.
  • Represented the Special Committee of the Board of Directors of a provider of bulk liquid storage services in its US$419M and US$112M sales of subsidiaries to an agricultural commodity merchant.

Capital Markets

  • Represented an automotive business in its US$220M refinancing of senior secured notes.
  • Represented a physical therapy provider in its US$210M Rule 144A offering of senior unsecured notes.
  • Represented a global graphic design company in its US$200M Rule 144A offering of senior subordinated notes.
  • Represented a SPAC in its US$268M acquisition of a bulk liquid storage and liquid animal supplement businesses of an agricultural commodities distributor.
  • Represented the independent directors of a publicly traded REIT in the internalization of management functions.
Recent Experience
Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B
Court Square Capital Partners's Strategic Capital Investment in Team Select Home Care

Credentials

Education

Craig received his J.D. from the University of Michigan, where he was a member of the University of Michigan Law Review and the Order of the Coif. He received his M.A. in Economics from the University of Michigan. He received his B.A. from Columbia University.

    Admissions
    • Pennsylvania
    • New York

    Related Insights & News

    • Author, “A Buyer's Guide to Carelessly Losing Indemnification Rights,” Law360, June 2017
    • Author, “Loan-to-Own Strategies and the Private Equity Investor,” Practical Law, November 2008
    Recognitions
    Winston Attorneys Recognized in The Best Lawyers in America® 2024

    August 17, 2023

    Recognitions
    Winston & Strawn Recognized in Chambers USA 2023

    June 6, 2023

    Recognitions
    Winston & Strawn Attorneys Recognized in The Best Lawyers in America© 2023

    August 18, 2022

    Recognitions
    Winston & Strawn Recognized in Chambers USA 2022

    June 3, 2022

    In the Media
    Featured in Law360: Craig Godshall’s Move to Winston & Strawn

    June 3, 2021

    In the Media
    Featured in Reuters: Winston & Strawn Adds Craig Godshall To Corporate Group

    June 2, 2021

    Press Release
    Winston & Strawn Strengthens Corporate Practice with the Addition of Craig L. Godshall

    June 2, 2021

    View All Insights & News

    Capabilities

    Transactions
    Private Equity
    Mergers & Acquisitions
    Capital Markets
    Logo
    facebookinstagramlinkedintwitteryoutube

    Copyright © 2025. Winston & Strawn LLP

    AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising